occupational hygiene practices 113 biological monitoring 625 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP), parkinsonism 292 850 , 868 mechanical hazards 130 \200\2231 , lymphoproliferative disorders 330 599 media interviews 786 \200\2237 medial epicondylitis, methylene blue M machine-made mineral \201 bre (methylthioninium chloride) diagnostic criteria 257 medical evacuations (medivacs) 386 medical insurance, expatriates 387 in methaemo globinaemia (MMMF) 56 328 , 808 machinery hazards 130 \200\2231 magenta exposure, photodermatitis 250 methylene chloride 238 methylene-bis-2- medical kits for travel 383 medical records see prescribed diseases 853 magnetic \201 elds 24 maintenance, control measures 635 chloroaniline, biological monitoring 625 records medical reports see reports 50_Smedley_Index.indd 905 1/2/2013 3:36:25 PM INDEX 906 monitoring, selection of sampling and analysis methods 606 National Institute for methylene-bis- Biological Standards and Controls (NIBSC) 713 orthochloroaniline exposure, RIDDOR reportable diseases 870 National Poisons monitoring Information Service (NPIS) 792 4,4-methylenedianiline (MDA), BMGV 627 methylmercury exposure, techniques 604 \200\2235 mortality rates 684 mortality statistics 692 \200\2233 motor neuropathy 296 moving walkways , legislation 527 mucosal irritation nausea and vomiting, air passenger travel 481 neck disorders, medical management 256 psychosis 306 methyl-n-butyl ketone exposure, RIDDOR reportable diseases 870 needlestick injuries associated hazards 816 counseling and support 818 4-methylpentan-2-one, ozone 101 sulfur dioxide 102 BMGV 627 methylthioninium chloride see methylene blue microbial pathogens 108 military personnel multidisciplinary follow-up 817 post-exposure occupational health services 345 prophylaxis 817 multi-ori \201 ce total inhalable hepatitis B 820 HIV 822 \200\2233 \201 tness assessment sampler 48 486 \200\2237 multiple myeloma 330 multi-resistant reporting procedures 818 restrictions from work 818 pilots 487 \200\2238 recruits 486 , 487 Staphylococcus aureus (MRSA), colonization of health care workers 252 post-con \202 ict illness 332 \200\2233 risk assessment 816 , 817 source testing 816 mineral oil exposure prescribed diseases 853 RIDDOR reportable diseases 870 mineral oil mist, sampling mushroom worker \200\231s Neisseria meningitidis 164 \200\2235 nerve agents 829 neurological effects 98 lung 206 mutagenesis 675 Mycobacterium and analysis 49 Mini-Mental State Examination (MMSE) 457 minimum sampling volumes 607 marinum 195 acetone 76 acrylamide 78 acrylonitrile 79 carbon disulphide 81 carbon monoxide 98 chlorofor m 82 n-hexane 88 hydrogen sulfide 99 lead 70 manganese 71 mercury 72 methyl ethyl ketone 87 pesticides 90 phenol 93 styrene 94 tetrachloroethylene 95 vinyl chloride 96 neuropathic pa in 296 neuropathies mylagic encephalomyelitis (ME) 460 \200\2231 myocardial infarction, karoshi 336 minimum school leaving N N,N -dimethylacetamide, age 523 mining prescribed diseases 856 , BMGV 627 naphthalene 329 naphthylamine exposure, 858 , 865 , 866 RIDDOR reportable diseases 870 , 871 prescribed diseases 853 see also coal dust; coalworker \200\231s pneumoconiosis narcosis, acute 290 \200\2231 emergency management 291 mirtazapine 458 in PTSD 314 miscarriage 320 \200\2231 mists legislation 291 nasal cancers 232 , 853 , 855 , 861 , 872 compression nasal irritation, styrene 94 nasal mucosal neuropathies 294 \200\2235 de \201 nition and diabetes mellitus 462 organophosphate- induced 298 \200\2239 examples 45 metal working \202 uids (MWFs) 61 organic 114 \200\22315 sampling and analysi s 49 atrophy 232 \200\2233 nasal polyps 232 \200\2233 nasal septal perforation peripheral arsenic 63 chromium 66 neuropathies 296 \200\2237 neuropsychiatric disease 851 neurotoxicity 852 neutrons 16 neutropenia, bone marrow mixtures, evaluation of exposure 616 models of occupational nasal septal ulceration 232 \200\2233 nasal sinuses, cancer 73 , 232 , 853 , 855 , 861 , 872 health provision 344 \200\2235 nasopharyngeal advantages and carcinoma 866 national audit 355 National Director for aplasia 324 \200\2235 disadvantages of different models 345 new mothers, health and safety regulations 524 \200\2235 current and future Health and Work 395 , 396 developments 346 50_Smedley_Index.indd 906 1/2/2013 3:36:25 PM INDEX 907 occupational non-malfeasance 360 non-randomized, controlled New Zealand yellow \202 ags history-taking 446 occupational hygiene, de \201 nition 598 occupational hygiene system, chronic pain 754 interventions 704 no observable adverse NHS Health at Work Network 397 effects level (NOAEL) 600 , 672 NHS Plus 397 NICE, guidance on exposure monitoring 600 note-taking, sickness absence management 406 occupational occupational health consultations 748 \200\2239 hygiene reports, assessment 774 \200\2235 occupational hygienists 343 role and function 598 occupational illness 341 occupational physicians nickel 73 noti \201 able diseases of animals, BSE 162 prescribed diseases 853 RIDDOR reportable diseases 869 , 872 nicotine addiction 565 nicotin e replacement noti \201 able human diseases 535 anthrax 177 \200\2236 brucellosis 185 \200\2234 hepatiti s B 153 hepatitis C 155 legionnaires \200\231 therapy (NRT) 391 (OHPs) 342 odds ratio 686 Of \201 ce for Nuclear Regulation 512 Offshore Installations night work 140 \200\2231 health assessments 574 , 756 \200\2237 disease 168 \200\2239 and pregnancy 570 risk management 389 working time meningococcal and Pipeline Works (First Aid) Regulations 1989 537 oil folliculitis 249 oil mist (metal wo rking infections 165 SARS (severe acute respiratory syndrome) 173 regulations 574 nitrates, water contamination 719 tetanus 171 \200\2230 tuberculosis 167 viral haemorrhagic fevers 159 \202 uids) 61 nitriles, cyanide oil platforms, medical poisoning 796 \200\2239 nitrogen dioxide 100 role in sick building syndrome 334 nitrogen ox ides, respirator cover 537 older employees nuclear weapons, terrorist \201 tness for work 452 \200\2233 health interventions 453 attack 832 \200\2233 one-tailed p -values 688 operational pressures, and \201 lters 657 noise O obesity 454 \200\2235 ill-health retirement 413 audiometry opioids 755 optical radiation 26 \200\2237 screening 764 \200\2235 Control of Noise at BMI calculator 882 \200\2235 occupational exposure limits (OELs) 678 \200\2239 adjustment t o periods of lasers 28 \200\2239 Work Regulations 2005 548 \200\2239 orf 112 , 194 , 195 , 850 organic compounds, and \201 tness for work 4 \200\2235 hearing protectors 658 \200\2239 sampling and analysis 50 organic dust toxic syndrome work >8 hours 614 \200\22315 prediction of noise occupational hazards, classi \201 cation 599 reduction 660 \200\2231 (ODTS) 204 organic dusts and mists 114 \200\22315 organic lead exposure instrumentation 6 \200\2237 legislation 7 , 303 L EPd determination 7 prescribed diseases 8 43 \200\2234 risk assessment and management 5 occupational health advisers (OHAs) 342 \200\2233 occupational health biological monitoring 625 health surveillance 436 \200\2237 psychosis 306 assessment, obtaining consent 839 \200\22340 occupational health nurses organizational hazards 599 organizational pressures, noise assessments 778 (OHNs) 342 \200\2233 administration of noise monitoring survey and ill-health retirement 413 data form 779 immunizations 374 \200\2235 occupational health service noise-induced hearing organizational solution to exposure control 638 loss 302 \200\2233 audiometry 432 models 344 \200\2235 advantages and organochlorine nomograms, lung function disadvantages of different models 345 pesticides 90 organomercurials tests 760 non-Hodgkin \200\231s current and future food contamination 723 poisoning 805 organophosphate pesticides 90 lymphoma 330 non-ionizing radiation developments 346 occupational health services, electromagnetic \201 elds 24 eye injuries 278 \200\2239 , 280 lasers 28 \200\2239 optical radiation 26 \200\2237 general principles 340 \200\2231 as chemical weapons 829 poisoning 298 , 802 occupational health team 342 \200\2233 50_Smedley_Index.indd 907 1/2/2013 3:36:25 PM INDEX 908 biological effect diesel engine exhaust orlistat 455 ornithosis 188 \200\2239 orthotoluidine exposure, monitoring 624 dermal exposure 618 organophosphate emissions (DEEE) 57 sampling and analysis 49 parvovirus B19 ( \201 fth disease) 320 prescribed diseases 853 poisoning 298 , 802 osteoarthritis 847 parkinsonism 292 risk phrases 90 sampling and analysis 50 skin decontamination 803 water co ntamination 719 workplace exposure passive monitoring 604 patch sampling 620 patent fuel manufacture from pitch, skin surveill ance 426 pathogens, as biological hip 260 \200\2231 osteo \202 uorosis 718 osteolysis of terminal phalanges 854 osteonecrosis, dysbaric 546 , 842 , 867 weapons 830 paths, legislation 526 patient group directions (PGDs) 374 \200\2235 otosclerosis 432 , 433 ototoxicity, styrene 94 outdoor air limits 92 pharmaceuticals, water contamination 719 phenelzine, in PTSD 314 phenic acid see phenol phe nol 93 pollution 714 \200\22315 Patient Health over-3-day injuries, de \201 nition 534 overwork, karoshi 336 ovine chlamydiosis 188 \200 \2239 , Questionnaire (PHQ9) 751 biological monitoring 625 poisoning 806 \200\2237 phenolum see phenol phenyl hydrate see ph enol phenylic acid see phenol phorate PCV drivers, \201 tness to drive 474 850 peak sound pressure level oxygen saturation, during (L cpeak ) 4 air passenger travel 480 , 481 PEF (peak expiratory risk phrases 90 workplace exposure oxygen therapy \202 ow) 760 serial peak \202 ow in anaphylaxis 814 in hydrogen sulfide poisoning 801 limits 92 testing 762 \200\2233 see also pesticides phosphorus exposure, penicillin, in meningococcal infection 164 pension schemes 413 pentachlorophenol, in mercury poisoning 804 , prescribed diseases 851 805 phossy jaw 851 photo retinitis (blue light in phenol poisoning 807 ozone 101 biological monitoring 625 perchloroethylene hazard) 12 photodermatitis 250 photokeratitis 12 phototherapy, for jet P p -values 688 pacemaker insertion, expected time off work 409 (tetrachloro ethylene) 95 biological monitoring 625 peripheral neuropathy lag 145 296 \200\2237 , 851 , 852 , 855 , 870 phthalates, water peritendinitis, medical management 256 permanence of illness 412 personal data, contamination 719 phthalic anhydride 77 physical environment 372 physical hazards 599 physi cal impairment, de \201 nition 564 pain chronic pain management 754 \200\2235 de \201 nition 578 personal protective classi \201 cation 754 pain toolkit 755 pancreatic cancer 270 pandemic in \202 uenza 174 pandemic planning 175 pa raquat equipment (PPE) 634 picloram de \201 nition 650 eye and face risk phrases 90 workplace exposure protection 666 \200\2237 limits 92 gloves 662 \200\2233 legal requirements 650 protective clothing 664 setting up a PPE see also pesticides pigmentation disorders health effects 90 risk phrases 90 workplace exposure 248 pilonidal sinus surgery, expected time off work 409 pilots, \201 tness for work 484 \200 \2235 limits 92 program 650 \200\2231 see also pesticides paratertiarybutylphenol exposure, prescribed diseases 854 parkinsonism 292 \200\2233 use 650 see also hearing protectors; respiratory protective equip personal sampling 604 , 612 personality types 450 military pilots 487 \200\2238 pitch exposure manganese exposure 307 prescribed diseases 853 RIDDOR reportable diseases 870 skin surveillance 426 paroxetine, in PTSD 314 partial enclosure with extraction 640 particle \201 lters 654 par ticulates 714 and heart disease risk 238 person-years method, statistical analysis 701 plague 830 pesticides 90 50_Smedley_Index.indd 908 1/2/2013 3:36:25 PM INDEX 909 health and safety soil 720 \200\2231 water 718 \200\22319 pollution control, Environmental Protection Act 199 0 586 \200\2237 plants, photodermatitis 250 pleural disorders regulations 524 \200\2235 , 527 lead avoidance 436 legislation 321 work exposures 321 asbestos-related 214 \200\22315 benign 230 mesothelioma 230 \200\2231 pre-placement pleural effusion, benign 230 pleural plaques 230 pneumoconioses 216 \200\22317 , assessments 448 \200\2239 prescribed diseases 560 , polyaromatic hydrocarbons (PAHs), BMGV 627 polychlorinated biphenyls 841 \200\22366 871 press conferences 785 press releases 784 \200\2235 pressure changes, air (PCBs) asbestosis 220 berylliosis 224 coal dust exposure 49 coal worker \200\231s rice oil contamination 723 passenger travel 480 water contamination 719 prevalence rates 684 prevention see exposure polycyclic aromatic hydrocarbons, photodermatitis 250 pneumoconiosis 218 \200\22319 kaolin pneumoconiosis 225 prevention polyps, nasal 232 \200\2233 population attributable silicosis 222 \200\2233 \200\230simple \200\231 226 prion diseases bovine spongiform encephalopathy (BSE) 162 variant Creutzfeldt \200\223 Jakob disease (vCJD ) 160 \200\2231 process design 638 , 639 progressive massive \201 brosis risk 686 pneumothorax, \201 tness for post-con \202 ict illness, military air passenger travel 482 point source air pollution, health effects 715 personnel 332 \200\2233 post-exposure poisoning prophylaxis 817 hepatitis B 820 , 821 HIV 822 \200\2233 carbon monoxide 794 \200\2235 contact details for (PMF) 218 post-traumatic stress disorder (PTSD) specialist advice 792 prohibition notices 513 proportional rates 684 \200\2235 propranolol, in PTSD 314 protected period, pregnancy 570 protective clothing 664 protocols, epidemiological investigations 69 4 Provision and Use of Work Equipment Regulations 1998 530 cyanide 796 \200\2237 diagnosis and treatment 798 \200\2239 hydro \202 uoric acid 810 hydrogen sulfide 800 \200\2231 immediate assessment 312 \200\22313 distinguishing false from genuine symptoms 315 management 792 epidemiology 312 legislation 315 management 314 \200\22315 prognosis 314 risk factors 313 \200\22312 mercury 804 \200\2235 methaemo- globinaemia 808 organophosphates 802 \200\2233 phenol 806 \200\2237 RIDDOR reportable disea ses 869 role of occupational health 792 pseudo-gynaecomastia 322 psittacosis 188 \200\2239 psychiatric conditions \201 tness to w ork with children 499 posture 124 \200\2236 legislation and guidance 126 risk controls 125 potassium cyanide policies see also mental health poisoning 796 \200\2239 pralidoxime mesilate, expatriates 386 \200\2237 health and safety 368 \200\2239 immunization 374 \200\2235 mental health 376 \200\2237 sickness absence 370 \200\2231 substance abuse 378 \200\22380 travel 382 \200\2234 violence psychiatric in organophosphate poisoning 802 emergencies 824 \200\2235 psychodynamic precautionary principle 419 , psychotherapy 753 710 psychological \201 rst aid 314 \200\22315 precision of assays 606 predicted mean vote (PMV), thermal comfort 38 psychological management 388 \200\2239 wellness/wellbeing 372 \200\2233 workplace smoking therapies 752 \200\2233 access issues 753 predicted percentage dissatis \201 ed (PPD), thermal comfort 38 psychoses 306 \200\2237 \201 tness for air passenger 390 \200\2231 policy writing 366 \202 ow chart 367 travel 483 psychosocial factors and \201 tness for pre-employment screening 566 pregnancy pollution work 450 \200\2231 in long-term sickness absence 407 adverse outcomes 320 \200\2231 chlamydiosis risk 188 discrimination 570 \200\2231 \201 tn ess for air passenger de \201 nition 586 indoor air pollution 716 \200\22317 role in short-term sickness outdoor air absence 405 travel 482 pollution 714 \200\22315 50_Smedley_Index.indd 909 1/2/2013 3:36:25 PM INDEX 910 R rabies 868 radial tunnel syndrome 294 radiation see Occurrences Regulations (RIDDOR) 1995 534 \200\2235 psychosocial hazards 134 , 599 adverse effects 134 \200\2235 lone working 138 \200\2239 long working hours 142 risk contro ls 135 role in sick building syndrome 335 RIDDOR reportable diseases 867 \200\22373 reporting schemes 692 \200\2233 reports electromagnetic \201 elds; ionizing radiation; lasers; optical radiation, terrorist attac k 832 \200\2233 Access to Medical Reports Act 1988 580 \200\2231 shift and night radiofrequency \201 elds communication of output 363 and disability 565 \201 tness for work work 140 \200\2231 (RFs) 24 time zone changes 144 \200\2235 violence and randomized controlled interventions 704 randomized controlled aggression 136 \200\2237 assessments 444 \200\2235 psychrometers 31 public authorities, de \201 nition 582 pulmonary \201 brosis trials, assessment 782 Raynaud \200\231s phenomenon 854 research case-control hand-transmitted vibration 10 scleroderma 251 studies 702 \200\2233 cohort studies 700 \200\2231 cross-sectional surveys 698 aluminum exposure 62 cobalt 67 nickel 73 reasonable adjustments for disability 567 \200\2238 experimental pulmonary oedema records studies 704 \200\2235 investigation of disease clusters 696 \200\2237 hydrogen sulfide 99 ozone 101 sulfur dioxide 102 pushing and pulling of loads, ergonomics a ssessments 776 access rights 579 archiving 350 \200\2231 con \201 dentiality 362 electronic 348 \200\2239 \201 tness for work research papers, interpretation and assessment 782 assessments 445 health surveillance 425 noise monitoring survey research planning, epidemiological investigations 694 \200\2235 respirable dusts, de \201 nition and examples 45 pyrethrin risk phrases 90 see also pesticides data form 779 of occupational health pyrethrum risk phrases 90 see also pesticides consultations 748 \200\2239 respirator users, \201 tness for security 348 \200\2239 , 350 transfer 350 of workplace work 500 respirators 654 \201 lters 654 gas/vapor \201 lters 657 protection values 656 types 655 Q Q fever 112 , 190 \200\2231 , 320 , inspections 772 registers of occupational 850 , 868 quality 352 disease 692 Registration, Evaluation, respiratory disease external standards 354 , Authorization and Restriction of Chemicals (REACH) regulations 42 , 554 \200\2235 , 676 \201 tness for air passenger travel 482 , 483 see also lung damage; pulmonary \201 bros is; pulmonary oedema 355 quality assurance 353 , 607 in health surveillance 424 quality improvement 352 \200\2233 quality systems 354 , 355 quantal dose \200\223response r elationship 672 rehabilitation 394 in chronic fatigue respiratory health surveillance 428 \200\2239 respiratory protective equipment (RPE) syndrome/myalgic encephalomyelitis 460 \200\2231 quarrying \201 t testing 653 maintenance 635 protection factors 652 protection values 656 selection 652 \200\2233 types 654 \200\2235 prescribed diseases 856 , in depression 459 initiatives 396 865 RIDDOR reportable diseases 870 quartz (crystalline silica) rehabilitation services 410 \200\22311 relative risk 686 renal failure 272 renal toxicity 854 repetitive work 128 \200\2239 54 respiratory silicosis 222 \200\2233 questionnaires 695 respiratory health sensitization 675 , 678 glutaraldehyde 85 ergonomics respiratory tract irritation surveillance 429 assessments 776 Reporting of Injuries, acetone 76 acrylonitrile 79 carbon disulphide 81 quinone exposure, prescribed diseases 852 Disease and Dangerous 50_Smedley_Index.indd 910 1/2/2013 3:36:25 PM INDEX 911 safety representatives lead exposure 538 new and expectant mothers 524 cyclic anhydrides (acid anhydrides) 77 formaldehyde 84 glutaraldehyde 85 hydrogen sulfide 9 9 isocyanates 86 methyl ethyl ketone 87 nitrogen dioxide 100 ozone 101 tetrachloroethylene 95 and safety committees 516 \200\22317 safety spectacles 666 Safety Statistics Bulletin, noise 5 noise exposure 548 \200\2239 scienti \201 c uncertainty 420 sources of scienti \201 c evidence 420 HSE 736 Salmonella 192 sample size requirements 613 sample statistics 688 sample types 604 sampling vibration exposure 550 young people at work 523 respiratory tract sensitization, isocyanates 86 responsible person, de \201 nition 534 res t periods 575 rests areas, legislation 527 resuscitation, risk communication 421 risk management biological monitoring 625 errors and conceptual model 417 frameworks 418 general principles 418 need and context 416 noise 5 pre cautionary corrections 607 ethical considerations 630 \200\2231 exposure monitoring program design 612 \200\22313 measurement of dermal exposure 620 \200 \2231 anaphylaxis 814 reticulocytosis, lead exposure 70 retinal burns 284 \200\2235 retinal detac hment, expected principle 419 terminology 416 violence 389 risk perception 421 ritonavir, post-exposure HIV prophylaxis 822 minimum sampling volumes 607 optimum sampling times 631 time off work 409 retirement road safety 742 \200\2233 roadways, legislation 526 Robens due to ill-health 412 \200\22313 forced 572 practical considerations 630 retrospective cohort studies 700 reversible effects, de \201 nition 675 Commission,1970 510 sampling methods, selection 606 room dimensions, legislation 526 rosin fume sampler 48 rosin-based solder \202 ux sampling needs, prioritization 609 rheumatoid factor, Caplan \200\231s sand blasting syndrome 219 fume 59 prescribed diseases 856 RIDDOR reportable diseases 871 rhinitis 198 \200\223233 rotational assignments 387 rotator cuff tendinitis, cyclic anhydrides (acid anhydrides) 77 diagnostic criteria 257 SARS (severe acute respiratory syndrome) 172 \200\2233 latex allergy 202 organic dusts and mists 114 ribavirin, in viral rotenone risk phrases 90 workplace exposure saturation diving limits 92 skin infections 252 see also diving haemorrhagic fever 159 see also pesticides rice oil disease 723 RIDDOR reportable diseases 867 scleroderma 251 , 854 Scotland, Healthy Working routine health statistics 692 \200\2233 Lives service 346 Scottish Environmental Protection Agency (SEPA) 588 rifampicin, meningococcal prophylaxis 164 rubber process dust/fume 58 sampling and analysis 49 ringworm 194 Rinne \200\231s test 303 risk, de \201 nition 416 risk assessment rubella 320 RV (residual volume) 880 screening for alcohol and drugs 758 \200\2239 audiometry 764 \200\2235 S safety see health and conceptual model 417 display screen equipment 528 expectant and new mothers 571 seafarers safety color vision safety critical jobs 504 \200\2235 testing 766 \200\2237 \201 tness categories 502 \201 tness for work 502 \200\2233 color vision \201 re risk 738 \200\2239 frameworks 418 general principles 418 hazardous testing 766 \200\2237 and diabetes mellitus 463 and epilepsy 465 \201 tness for work seasonal allergic rhinitis 565 substances 532 \200\2233 seasonal in \202 uenza 174 seating, legislation 526 security, during travel 382 assessment 504 \200\2235 safety reports, COMAH regulations 590 health and safety legislation 518 , 520 \200\2231 50_Smedley_Index.indd 911 1/2/2013 3:36:26 PM INDEX 912 silica, sampling and analysis 49 prescribed diseases 858 RIDDOR reportable diseases 869 , 813 security of records 350 electronic records 348 \200\2239 silicosis 54 , 216 , 222 \200\223858 , seizures see epilepsy selective serotonin reputake inhibitors (SSRIs) 458 869 slurry, soil pollution 721 smallpox 830 smoke, de \201 nition and examples 45 and associated lung cancer 865 coal miners 218 silt, soil pollution 721 \200\230simple \200\231 sensitive personal data, de \201 nition 578 smoking, risks after asbestos exposure 215 , 220 smoking cessation 391 smoking policies 390 \200\2231 social environment 372 \200\2233 Social Security (Prescribed Diseases) Regulatio ns 1985 560 sensitivity of assays 606 sensorineural HAVS, pneumoconioses 226 sinonasal cancer 73 , 232 , 853 , 855 , 861 , 872 Stockholm workshop scale 768 sensory neuropathy 296 serial peak \202 ow skin testing 762 \200\2233 seroconversion illness, dermal absorption 678 dermal exposure 617 \200\22318 measurement and uptake estimation 620 \200\2231 Soderberg process 853 , 870 sodium cyanide HIV 156 sertraline 458 severe acute respiratory poisoning 796 \200\2239 sodium nitrite, in cyanide poisoning 798 \200\2239 sodium thiosulph ate, in skin corrosion, phenol 93 skin decontamination hydro \202 uoric acid exposure 812 syndrome (SARS) 172 \200\2233 sewage sludge, soil pollution 721 cyanide poisoning 798 \200\2239 sex discrimination 570 \200\2231 sex hormones, water pesticides 803 phenol 807 skin disorders software security 348 \200\2239 software solutions to contamination 719 sexual harassment 570 Shaver \200\231s disease 216 shift work 140 \200 \2231 exposure control 638 cancers 247 , 853 , 870 contact urticaria 246 de-fatting, methyl ethyl soil pollution 720 \200\2231 solder fumes rosin-based solder \202 ux and diabetes mellitus 463 heart disease risk 238 during pregnancy 321 ketone 87 fume 59 dermatitis 242 \200\2235 , 861 folliculitis and acne 249 photodermatitis 250 pigmentation sampling and analysis 50 solvents shoulder disorders biological monitoring 625 water contamination 719 diagnostic criteria 257 medical management 256 prognosis 256 \200\2237 sick building syndro me (SBS) 334 \200\2235 , 716 disorders 248 RIDDOR reportable diseases 867 scleroderma 251 in sensory somatic effects, ionizing radiation 17 sound level meters (SLMs) 6 calibrators 7 sick pay 370 sickness absence 341 special waste, de \201 nition 586 speci \201 city of assays 606 spectacles, display scree n equipment users 529 de \201 nition and size of the neuropathy 296 problem 402 skin infections 252 zoonotic 194 \200\2235 in diabetes mellitus 462 evidence-based recovery skin irritation \200\230spiked \200\231 samples 607 spina bi \201 da, association with times 408 acrylamide 78 carbon disulphide 81 formaldehyde 84 glutaraldehyde 85 styrene 94 tetrachloro ethylene 95 expected times off work for procedures 409 latex allergy 202 spinal pathology, red and ill-health \202 ags 255 spirometry 760 \200\2231 spleen toxicity, vinyl chloride 96 retirement 412 long-term 394 , 406 \200\2237 measurement 402 \200\2233 and obesity 455 olde r employees 452 patterns 402 rehabilitation 394 risk factors 402 , 404 \200\2235 short-term 404 \200\2235 skin notation 617 skin patch testing 244 skin prick testing 199 in latex allergy 202 skin s ensitization 675 squamous cell carcinoma, skin 247 standardized rates 685 stannosis 216 , 226 state bene \201 ts 560 cobalt 67 cyclic anhydrides (acid anhydrides) 77 glutaraldehyde 85 isocyanates 86 nickel 73 sickness absence sickness bene \201 ts 400 policies 370 \200\2231 sickness bene \201 ts 400 static pressure, de \201 nition 647 static samples 604 statistical analysis, cohort assessment of skin stripping 620 skin surveillance 426 slate workers eligibility 401 siderosis 216 , 226 sievert (Sv) 17 studies 701 statistical inference 688 \200\2239 50_Smedley_Index.indd 912 1/2/2013 3:36:26 PM INDEX 913 T tailored frequency hearing protectors 658 \200\2239 tar exposure, prescribed suicide risk assessment 824 suit sampling 620 sulfotep research paper assessment 783 statistics, sources of routine risk phrases 90 workplace exposure data 692 \200\2233 statute law 558 statutory regulations 558 Statutory Sick Pay (SSP) 400 s teatosis 268 stochastic effects, ionizing diseases 853 limits 92 tar oils/ tar acids exposure see phenol, RIDDOR reportable diseases 870 see also pesticides sulfur dioxide 102 suppression of hazardous teachers substances 638 surface monitoring 621 surgical procedures expected time off work 409 \201 tness to work 498 , 499 voice disorders 236 radiation 17 Stockholm workshop temperature of scale, vibration white \201 nger 768 workplaces 526 tenofovir, post-exposure HIV prophylaxis 822 \201 tness for air passenger stomach cancer 270 \200\2231 stonemasonry travel 483 tenosynovitis 843 , 867 prescribed diseases 857 , surveillance diagnostic criteria 257 medical management 256 prognosis 256 \200\2237 865 asbestos exposed RIDDOR reportable diseases 871 Streptococcus suis 112 , 182 \200\2233 , 849 , 868 workers 1 , 214 \200\22315 audiometry 430 \200\223765 benzene 325 bladder cancer 275 cadmium workers 272 CJD 161 coal miners 219 disclosure of results 425 in exposure to organic dusts and mists 115 terminal illness, ill-health retirement 413 termination of pregnancy, expected time off work 409 terrorism 828 stress assessment 309 \200\22310 causal exposures/ industries 309 clinical features 308 de \201 n ition 308 epidemiology 308 individual biological weapons 830 \200\2231 chemical weapons 829 radiation and nuclear weapons 832 \200\2233 frequency 424 general principles 424 hand \200\223arm vibration syndrome 438 \200\2239 haza rdous substances exposure 533 hearing 303 , 549 hepatic angiosarcoma tetanus 170 , 868 tetrachloroethylene susceptibility 309 interventions 311 legislation 310 prevention 311 travel-related 382 (perchloroethylene) 95 biological monitoring 625 thermal comfort 38 thermal environment assessment of cold exposure 36 \200\2237 assessment of heat exposure 34 \200\2235 heat stress monitors 32 instrumentation 30 \200\2231 temperat ure of air passenger travel 481 264 see also post-traumatic stress disorder hepatic cirrhosis 267 inorganic lead stroboscopic effects 13 strontium chromate exposure 434 \200\2235 ionizing radiation 325 lead exposure 326 lead alkyls 436 \200\2237 exposure, prescribed diseases 865 study designs 704 \200\2235 styrene 94 workplaces 526 thermal balance 30 thermal environment control 38 \200\2239 organophosphate exposure 299 quality assurance 424 records 425 respiratory health 428 \200 \2239 respiratory sensitizer exposure 200 biological monitoring 625 subcutaneous cellulitis 262 , 842 , 867 substance abuse thermal radiation exposure, prescribed diseases 842 epidemiology 378 legislation 379 \200\230soft signs \200\231 468 substance abuse thermal sensation, seven skin 426 silicosis 223 vibration exposure 301 , point scale 39 thermoluminescent policies 378 \200\22380 dosemeters (TLDs) 20 551 substances, de \201 nition 532 substances of very high thermometers 30 \200\2231 THOR (The Health and survey types 608 \200\2239 swamp fever 848 swine \202 u 174 swineherd \200\231s disease 8 48 synergistic effects 616 systemic effects, concern (SVHC) 554 Occupation Reporting Network) 693 threshold dose 672 thrombocytopenia, bone marrow aplasia 324 \200\2235 substitution, hazardous substances 638 Successful Health and Safety Management , HSE 728 \200\2239 de \201 nition 675 50_Smedley_Index.indd 913 1/2/2013 3:36:26 PM INDEX 914 trichloroethylene, biological US \200\223European Union Safe time-weighted average concentrations 614 time zone changes 144 \200\2235 tin ore exposure s iderosis 226 stannosis 216 TLC (total lung monitoring 625 Harbor Framework 579 trichloromethane (chloroform) exposure 82 V vaccination see prescribed diseases 855 trihalomethane, water contamination 719 trimellitic anhydride 77 Truvada, post-exposure HIV immunizations capacity) 880 valve surgery, expected time toilet facilities, off work 409 legislation 527 toluene, biological monitoring 625 tongue discoloration, vanadium 74 vanadium 74 prophylaxis 822 tuberculin skin test (TST) 166 biological monitoring 625 vapors de \201 nition and tuberculosis 166 \200\2237 , 849 , examples 45 diesel engine exhaust 869 tool use, hand-transmitted \201 tness to work with children 499 risk in silicosis 222 tungsten inert gas (TIG) vibration 10 \200\22311 emissions (DEEE) 57 variant Creutzfeldt \200\223Jakob disease (vCJD) 160 \200\2231 vasectom y, expected time tort 561 total enclosure under negative pressure 640 TOXBASE 792 toxic effects 674 \200\2235 toxic oil syndrome 723 toxicity assessment 676 \200\2237 toxicokinetics 674 toxicological data welding 60 off work 409 two-tailed p -values 688 VC (vital capacity) 880 vehicles, safety issues 742 veiling re \202 ections 13 velocity pr essure, de \201 nition 647 Venezuelan equine encephalitis 830 U ulcers 855 ultraviolet (UV) radiation 26 evaluation 676 \200\2237 toxicology de \201 nition 672 dose \200\223response venlafaxine 458 ventilation 642 \200\2233 control measures 27 exposure from lamps 12 health effects 27 sources of exposure 26 , relationship 672 \200\2233 occupational exposure performance assessment, LEV systems 646 \200\2237 limits 678 \200\2239 27 see also local exhaust ventilation (LEV) systems toxins, as biological weapons 830 toxoplasma 320 trade unions 340 training subtypes 27 uncertainty in evaluation of ventilation pneumonitis 206 ventilation systems, factors affecting performance 644 toxicological data 677 in risk assessment 416 , violence management 388 workers with hazardous substances 638 transfer of records 350 trans meridian displacement 420 unemployment, health vesicants 829 vibration exposure risks 394 universities, provisions for disabled students 411 upper limb disorders 256 \200\2237 Control of Vibration at Work Regulations 2005 550 \200\2231 hand \200\223arm vibration (jet lag) 144 \200\2235 transmissible spongiform encephalopathies bovine spongiform encephalopathy (BSE) 162 associations with mechanical factors 259 syndrome (HAVS) 295 , 300 \200\2231 hand-transmitted 10 \200\22311 health surveillance 438 \200\2239 RIDDOR reportable diseases 867 causal exposures/ industries 258 diagnostic criteria 257 ergonomics variant Creutzfeldt \200\223Jakob disease (vCJD) 160 \200\2231 assessments 776 transportation velocity, de \201 nition 647 transurethral resection of prostate (TURP), ex pected time off work 409 good practice whole-body 8 vibration magnitude guidelines 258 prevention 258 measurement 10 \200\22311 vibration white \201 nger 10 , urinary tract cancers 274 \200\2235 , 300 \200\223846 853 , 870 2,2 \200\231-dichloro-4, clinical assessment 768 \200\2239 trauma see injuries Travel Plans 372 travel policies 382 \200\2234 video exposure 4-methylene dianiline 83 rubber process dust/ monitoring 605 vinyl chloride monomer 96 expatriate policy 386 \200\2237 hepatic fume 58 urticaria 246 tremor 851 1,1,1-trichloroethane 266 angiosarcoma 264 \200\2235 prescribed diseases 854 latex allergy 202 50_Smedley_Index.indd 914 1/2/2013 3:36:26 PM INDEX 915 weight RIDDOR reportable diseases 870 skin surveillance 426 vinyl chloride monomer workplace exposure limits BMI calculator 882 \200\2235 WHO classi \201 cation 454 (WELs) 678 \200\2239 Workplace Health Connect 397 workplace inspections, documentation 772 weight conversion chart 884 \200\2235 weight reduction 455 weighting, sound levels 4 weight ing factors (Q), disease 251 violence and aggression 136 \200\2237 violence management policies 388 \200\2239 viral haemorrhagic feve rs 158 , 830 workplace smoking policies 390 \200\2231 workplace visits, record ionizing radiation 17 Weil \200\231s disease 180 , 848 welder \200\231s \202 ash 280 , 28 1 welding fumes 60 keeping 749 workplace wellness/ wellbeing 372 \200\2233 viral warts, zoonotic 194 vision testing workplaces, de \201 nition 526 , sampling and analysis 49 532 color vision wellness/wellbeing policies 372 \200\2233 testing 766 \200\2237 work-related illness 341 workstation minimum wet bulb globe temperature display screen equipment (WBGT) 34 users 529 requirements 528 \200\2239 reference values from BS visors 666 visual impairment, \201 tness to work with children 499 wrist disorders EN 27243 35 diagnostic criteria 257 osteoarthritis 300 writer \200\231s cramp 842 , 867 white \201 nger, vibration-induced see vibration white \201 nger visual problems, diabetes mellitus 462 vitiligo 248 , 854 voice disorders 236 \200\2237 volatile organic compounds whole-body vibration 8 wind chill index 36 , 37 windows, legislation 527 withholding consen t 363 wood dust 53 X X-rays 16 xylene, BMGV 627 role in sick building syndrome 334 prescribed diseases 861 , sampling and analysis 50 Y young people at work 572 866 VT (tidal volume) 880 vulnerable groups 710 RIDDOR reportable diseases 872 work area classi \201 cation, ionizing radiation 22 food contamination 722 de \201 nitions 523 health and safety legislation 521 , 522 W waist circumference 454 walk tests 760 War Pensions Scheme, asbestos-related diseases 215 washing facilities, legislation 527 waste, de \201 nition 586 waste disposal, Work Capability Assessment (WCA) 400 , 401 working time regulations 574 , 575 work equipment, de \201 nition 530 Z Zidovudine, post-exposure HIV prophylaxis 823 Work in Compressed Air Regulations 1996 546 \200\2237 zinc 75 zinc chromate exposure, prescribed diseases 865 workability 452 Working for a Healthier Tomorrow, National Director for Health and Work,200 8 397 Environmental Protection Act 1990 586 \200\2237 zoonoses 112 anthrax 176 brucellosis 184 chlamydiosis 188 \200\2239 enteric 192 glanders 17 8 leptospirosis 180 Lyme disease 186 \200\2237 Q fever 190 \200\2231 skin infections 194 \200\2235 , 252 Streptococcus suis 182 \200\2233 Working Time Regulations waste incinerators, soil pollution 721 1998 141 , 142 working time regulations watchful waiting, stressful 1998 574 \200\2235 events 314 \200\22315 water pollution 718 \200\22319 weaving, prescribed diseases 859 Weber \200\231s test 303 websites 875 \200\2236 working zone, hoods 647 Workplace (Health, Safety and Welfare) Regulations 1992 526 \200\2237 50_Smedley_Index.indd 915 1/2/2013 3:36:26 PM